IN2014DN01612A - - Google Patents
Info
- Publication number
- IN2014DN01612A IN2014DN01612A IN1612DEN2014A IN2014DN01612A IN 2014DN01612 A IN2014DN01612 A IN 2014DN01612A IN 1612DEN2014 A IN1612DEN2014 A IN 1612DEN2014A IN 2014DN01612 A IN2014DN01612 A IN 2014DN01612A
- Authority
- IN
- India
- Prior art keywords
- components
- situ
- spraying
- matrix
- course
- Prior art date
Links
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 abstract 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 238000011065 in-situ storage Methods 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000007921 spray Substances 0.000 abstract 1
- 238000005507 spraying Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition
- A61K48/0025—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid
- A61K48/0041—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition wherein the non-active part clearly interacts with the delivered nucleic acid the non-active part being polymeric
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102011114986A DE102011114986A1 (de) | 2011-09-28 | 2011-09-28 | Sprühsystem |
| PCT/EP2012/068889 WO2013045455A1 (de) | 2011-09-28 | 2012-09-25 | Sprühsystem zur erzeugung einer in situ gebildeten matrix |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2014DN01612A true IN2014DN01612A (de) | 2015-05-15 |
Family
ID=46924442
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1612DEN2014 IN2014DN01612A (de) | 2011-09-28 | 2012-09-25 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20140243395A1 (de) |
| EP (1) | EP2760437A1 (de) |
| JP (1) | JP2014527886A (de) |
| KR (1) | KR20140068089A (de) |
| AU (1) | AU2012314512A1 (de) |
| BR (1) | BR112014007443A2 (de) |
| CA (1) | CA2850253A1 (de) |
| DE (1) | DE102011114986A1 (de) |
| EA (1) | EA026717B1 (de) |
| IN (1) | IN2014DN01612A (de) |
| WO (1) | WO2013045455A1 (de) |
| ZA (1) | ZA201401557B (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3004331A1 (de) * | 2013-06-05 | 2016-04-13 | Fundación Pública Andaluza Progreso Y Salud | Verwendung von mesothelialen zellen in einem gewebe-bioengineering und in künstlichen geweben |
| US12064484B2 (en) | 2013-06-28 | 2024-08-20 | Ethris Gmbh | Compositions for introducing RNA into cells |
| JP2017507946A (ja) | 2014-02-26 | 2017-03-23 | エスリス ゲーエムベーハーethris GmbH | Rnaを胃腸内投与するための組成物 |
| US9655842B1 (en) | 2015-12-04 | 2017-05-23 | Covidien Lp | Injectable non-aqueous compositions and methods of treating vascular disease |
| US11013501B2 (en) | 2017-12-08 | 2021-05-25 | Davol, Inc. | Method of protecting the peritoneum against tearing and other injury before an active surgical intervention at or near the peritoneum |
| EP3628309A1 (de) * | 2018-09-28 | 2020-04-01 | Universität Heidelberg | Verfahren zur herstellung oraler dosierungsformen |
| ES3030742A1 (es) * | 2023-12-28 | 2025-07-01 | Univ Sevilla | Procedimiento de preparación de nanopartículas poliméricas de PLGA |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8815435D0 (en) * | 1988-06-29 | 1988-08-03 | Smith & Nephew | Non autoadherent dressings |
| US4938763B1 (en) * | 1988-10-03 | 1995-07-04 | Atrix Lab Inc | Biodegradable in-situ forming implants and method of producing the same |
| TW247878B (de) * | 1991-07-02 | 1995-05-21 | Takeda Pharm Industry Co Ltd | |
| EP0560014A1 (de) * | 1992-03-12 | 1993-09-15 | Atrix Laboratories, Inc. | Biologisch abbaubarer Wundverband in Form eines Sprühfilms und Verfahren zu seiner Herstellung |
| US6733767B2 (en) * | 1998-03-19 | 2004-05-11 | Merck & Co., Inc. | Liquid polymeric compositions for controlled release of bioactive substances |
| PT1063942E (pt) * | 1998-03-19 | 2004-10-29 | Merck & Co Inc | Composicoes polimericas liquidas para libertacao controlada de substancias bioactivas |
| US6103266A (en) * | 1998-04-22 | 2000-08-15 | Tapolsky; Gilles H. | Pharmaceutical gel preparation applicable to mucosal surfaces and body tissues |
| JP4540762B2 (ja) | 1999-01-18 | 2010-09-08 | 本田技研工業株式会社 | 排気2次空気弁を備えた鞍乗型車両 |
| CN1684663A (zh) | 2002-07-31 | 2005-10-19 | 阿尔萨公司 | 可注射的多模式聚合物储库组合物以及其用途 |
| AU2004313245B2 (en) | 2003-12-30 | 2011-04-14 | Durect Corporation | Polymeric implants, preferably containing a mixture of PEG and PLG, for controlled release of active agents, preferably a GNRH |
| US8097239B2 (en) * | 2005-06-06 | 2012-01-17 | Camurus Ab | Controlled-release formulations |
| JP2009533455A (ja) * | 2006-04-12 | 2009-09-17 | マサチューセッツ インスティテュート オブ テクノロジー | 癒着を阻害するための組成物および方法 |
| WO2010142660A2 (en) * | 2009-06-09 | 2010-12-16 | Novartis Ag | Drug delivery system |
| US9649331B2 (en) | 2009-08-27 | 2017-05-16 | Ara Medical Llc | Sprayable polymers as adhesion barriers |
-
2011
- 2011-09-28 DE DE102011114986A patent/DE102011114986A1/de not_active Withdrawn
-
2012
- 2012-09-25 EA EA201400388A patent/EA026717B1/ru not_active IP Right Cessation
- 2012-09-25 KR KR1020147007764A patent/KR20140068089A/ko not_active Withdrawn
- 2012-09-25 EP EP12762603.4A patent/EP2760437A1/de not_active Withdrawn
- 2012-09-25 IN IN1612DEN2014 patent/IN2014DN01612A/en unknown
- 2012-09-25 JP JP2014532354A patent/JP2014527886A/ja active Pending
- 2012-09-25 US US14/347,920 patent/US20140243395A1/en not_active Abandoned
- 2012-09-25 CA CA2850253A patent/CA2850253A1/en not_active Abandoned
- 2012-09-25 AU AU2012314512A patent/AU2012314512A1/en not_active Abandoned
- 2012-09-25 WO PCT/EP2012/068889 patent/WO2013045455A1/de not_active Ceased
- 2012-09-25 BR BR112014007443A patent/BR112014007443A2/pt not_active IP Right Cessation
-
2014
- 2014-02-28 ZA ZA2014/01557A patent/ZA201401557B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2760437A1 (de) | 2014-08-06 |
| AU2012314512A1 (en) | 2014-03-20 |
| KR20140068089A (ko) | 2014-06-05 |
| EA026717B1 (ru) | 2017-05-31 |
| EA201400388A1 (ru) | 2014-08-29 |
| ZA201401557B (en) | 2015-09-30 |
| CN103930097A (zh) | 2014-07-16 |
| DE102011114986A1 (de) | 2013-03-28 |
| JP2014527886A (ja) | 2014-10-23 |
| BR112014007443A2 (pt) | 2017-04-04 |
| US20140243395A1 (en) | 2014-08-28 |
| CA2850253A1 (en) | 2013-04-04 |
| WO2013045455A1 (de) | 2013-04-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2014DN01612A (de) | ||
| WO2012018446A3 (en) | Anchor delivery system | |
| WO2012091952A3 (en) | Median lobe retraction apparatus and method | |
| WO2011112248A3 (en) | Methods and devices for real time monitoring of collagen and for altering collagen status | |
| WO2012091956A3 (en) | Continuous indentation lateral lobe apparatus and method | |
| MX2017017090A (es) | Compuestos derivados de sulfamida de 1,3,4-oxadiazol como inhibidor de histona desacetilasa 6, y la composicion farmaceutica que comprende los mismos. | |
| GB201019577D0 (en) | Method | |
| EP3808367A3 (de) | Abzielung auf aneurysma durch modulation von phagozytosesignalwegen | |
| EP4461326A3 (de) | Flexibles system zur freisetzung eines ankers | |
| WO2012091954A3 (en) | Median lobe destruction apparatus and method | |
| NZ611606A (en) | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity | |
| WO2012091955A3 (en) | Median lobe band implant apparatus and method | |
| PH12016500866A1 (en) | Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof | |
| MY167691A (en) | A pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroid | |
| WO2016113550A3 (en) | Dressing | |
| MX2013002932A (es) | Formulaciones agricolas liquidas de estabilidad mejorada. | |
| WO2014093489A3 (en) | Hydrogel membrane for adhesion prevention | |
| EP4477157A3 (de) | Expandierbare gewebeeingriffsvorrichtung | |
| HK1198921A1 (en) | Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof | |
| WO2014104974A3 (en) | Self-assembling ultrashort peptides modified with bioactive agents by click chemistry | |
| WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
| EP3606570B8 (de) | Arzneizusammensetzungen auf der basis von kollagenpeptid zur verwendung in der behandlung augenkrankheiten, -störungen oder -wunden | |
| WO2012109535A3 (en) | Amino acid derivatives and absorbable polymers therefrom | |
| EP2407147A3 (de) | Zusammensetzung mit biologisch regenerativer, restaurativer und eutrophierender Aktivität | |
| HK1216839A1 (zh) | 调整释放制剂 |